Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Helix BioMedix Appoints Jack Clifford to Board of Directors; Moves Small Molecule Pharmaceutical Program Forward
October 5th, 2007
Helix BioMedix, Inc., (OTCBB: HXBM), a biopharmaceutical company with an extensive library of diverse bioactive peptides, announced the appointment of Jack Clifford to its board of directors, and its progress in the achievement of strategic milestones. "Jack brings to Helix BioMedix extensive experience and industry relationships at an important point in the company's development," commented R. Stephen Beatty, President and Chief Executive Officer of Helix BioMedix, regarding the appointment of Mr. Clifford. "His past expertise with negotiating license agreements for both consumer and pharmaceutical peptide applications with companies such as Neutrogena, Merck and C.R....
Source: Health Business Week (2007-10-05)
|
